Disclosure Of Fair Value Measurement [Text Block]

Ascelia Pharma - Filing #678716

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	87 072 SEK	—	—	—	—	—	—	218 569 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities	12 744 SEK	—	—	—	—	—	—	37 711 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	74 328 SEK	639 962 SEK	- SEK	34 871 SEK	671,000 SEK	74 328 SEK	678 747 SEK	180 859 SEK	- SEK	533 732 SEK	34 871 SEK	972,000 SEK	180 859 SEK	678 747 SEK	405 827 SEK	678 831 SEK	307 834 SEK	307 834 SEK	- SEK	254,000 SEK	34 576 SEK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]